Neuro-Adaptive Photobiomodulation Therapy System

A wearable photobiomodulation therapy system that integrates brain-computer interfaces, artificial intelligence, and machine learning algorithms to provide personalized, real-time treatment protocols for neurological disorders and other conditions.

The original patent application for photobiomodulation therapy garments demonstrated the potential for near-infrared light to treat various disorders. However, these early systems were limited by their fixed dosimetry and lack of real-time feedback. The new inventive concept addresses these limitations by incorporating advanced technologies to create a more sophisticated, adaptive, and effective treatment system.

The Neuro-Adaptive Photobiomodulation Therapy System consists of a wearable garment or device that incorporates multiple near-infrared light sources, sensors, and a brain-computer interface. The system utilizes artificial intelligence-driven algorithms to analyze real-time neural activity feedback and adjust near-infrared light dosimetry accordingly. This ensures optimal treatment efficacy and minimizes potential side effects. The system can also integrate machine learning algorithms to predict and adapt to individual user responses, further enhancing treatment outcomes. Additionally, the system can be configured to administer simultaneous, multi-wavelength near-infrared light therapy, where each wavelength is optimized for a specific biological effect.

The new inventive concept's integration of brain-computer interfaces, artificial intelligence, and machine learning algorithms represents a significant departure from the original patent's fixed dosimetry and lack of real-time feedback. The Neuro-Adaptive Photobiomodulation Therapy System's ability to adapt to individual user responses and provide personalized treatment protocols is a substantial improvement over existing photobiomodulation therapy systems.

Alternative embodiments of the Neuro-Adaptive Photobiomodulation Therapy System could include variations in the type and number of near-infrared light sources, sensors, and brain-computer interfaces used. Additionally, the system could be adapted for use in different treatment settings, such as clinical or home-based care, and could be integrated with other therapeutic modalities, such as electrical stimulation or cognitive training.

The Neuro-Adaptive Photobiomodulation Therapy System has significant commercial potential in the treatment of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and depression. The system could also be applied to other conditions, such as chronic pain, inflammation, and wound healing. The market for photobiomodulation therapy devices is expected to grow significantly in the coming years, driven by increasing awareness of the technology's potential benefits and the need for more effective treatment options.